References
- MacklonNSStoufferRLGiudiceLCFauserBCThe science behind 25 years of ovarian stimulation for in vitro fertilizationEndocr Rev20062717020716434510
- BairdDTA model for follicular selection and ovulation: lessons from superovulationJ Steroid Biochem1987271–315233121918
- BoschEEzcurraDIndividualised controlled ovarian stimulation (iCOS): maximising success rates for assisted reproductive technology patientsReprod Biol Endocrinol201198221693025
- YatesAPRustamovORobertsSAAnti-Mullerian hormone-tailored stimulation protocols improve outcomes whilst reducing adverse effects and costs of IVFHum Reprod20112692353236221672928
- FiedlerKEzcurraDPredicting and preventing ovarian hyperstimulation syndrome (OHSS): the need for individualized not standardized treatmentReprod Biol Endocrinol2012103222531097
- ChristenMSchertzJCArriagadaPKeitelJMüllerHThe redesigned follitropin α pen injector for infertility treatmentExpert Opin Drug Deliv20118683383921548843
- PlatteauPLaurentEAlbanoCAn open, randomized single-centre study to compare the efficacy and convenience of follitropin beta administered by a pen device with follitropin alpha administered by a conventional syringe in women undergoing ovarian stimulation for IVF/ICSIHum Reprod20031861200120412773446
- SomkutiSGSchertzJCMooreMFerrandeLKellyEGonal-F Prefilled Pen in OI Study 24785 GroupPatient experience with follitropin alfa prefilled pen versus previously used injectable gonadotropins for ovulation induction in oligoanovulatory womenCurr Med Res Opin200622101981199617022858
- WeissNGonadotrophin products: empowering patients to choose the product that meets their needsReprod Biomed Online2007151313717623531
- Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)Hum Reprod2004191414714688154
- SaundersHSchertzJCHeckerCLangBArriagadaPThe recombinant human chorionic gonadotropin prefilled pen: results of patient and nurse human factors usability testingExpert Opin Drug Deliv20129889390022703331
- AbbottsCSalgado-BragaCAudibert-GrosCA redesigned follitropin alfa pen injector for infertility: results of a market research studyPatient Prefer Adherence2011531533121792303
- SchertzJCSaundersHHeckerCLangBArriagadaPThe redesigned follitropin alfa pen injector: results of the patient and nurse human factors usability testingExpert Opin Drug Deliv2011891111112021843107
- PorterRKisselCSaundersHKeckCPatient and nurse evaluation of recombinant human follicle-stimulating hormone administration methods: comparison of two follitropin injection pensCurr Med Res Opin200824372773518230195
- Merck Serono Australia Pty LtdProduct Information: GONAL-f®PenFrenchs Forest NSW, AustraliaMerck Serono Australia Pty Ltd2014 Available from: https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2010-PI-03557-3Accessed February 25, 2014
- Popovic-TodorovicBLoftABredkjaeerHEBangsbøllSNielsenIKAndersenANA prospective randomized clinical trial comparing an individual dose of recombinant FSH based on predictive factors versus a ‘standard’ dose of 150 IU/day in ‘standard’ patients undergoing IVF/ICSI treatmentHum Reprod200318112275228214585873